[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352446-105":59,"doc-detail-352446-en":135},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":128,"head_meta":130,"extra_data":132,"updated_unix":134},105,"en","actionable-genomic-landscape-of-biliary-tract-cancer-in-the-indian-population","Actionable genomic landscape of biliary tract cancer in the Indian population","","Background: Biliary tract cancers (BTCs), including gallbladder cancer (GBC) and cholangiocarcinoma (CCA), are rare but aggressive malignancies with distinct molecular landscapes and poor outcomes. Genomic profiling has identified many alterations, yet the genomic landscape of BTCs in the Indian population remains insufficiently characterized. Methods: Retrospective analysis of 154 BTC cases (69 CCA, 85 GBC) used targeted sequencing panels to call somatic mutations, CNVs, and gene fusions, followed by enrichment and co-occurrence analyses. Results: TP53 (53%) was most frequent, with KRAS, ARID1A, IDH1, and PIK3CA also enriched. Subtype-specific alterations distinguished IDH1 in CCA and STK11 in GBC, while SMAD4-mutant, PD-L1–negative tumors showed reduced PD-L1 expression. Conclusions: The study defines actionable genomic differences and immune-associated features supporting personalized treatment.",{"@graph":69,"@context":127},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/actionable-genomic-landscape-of-biliary-tract-cancer-in-the-indian-population/352446/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/actionable-genomic-landscape-of-biliary-tract-cancer-in-the-indian-population/352446.png","ImageObject",300,407,{"name":92,"@type":93},"Levi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119,123],{"name":110,"@type":111,"acceptedAnswer":112},"What was the study’s main goal regarding biliary tract cancer in India?","Question",{"text":113,"@type":114},"To comprehensively characterize the mutation and genomic alteration landscape of BTC in the Indian population, including subtype-specific differences and immune-related associations.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were genomic alterations identified in the 154 BTC cases?",{"text":118,"@type":114},"Researchers retrospectively analyzed 154 BTC cases using data from targeted sequencing panels, detecting somatic mutations, copy number variations, and gene fusions, then running pathway enrichment and mutual exclusivity/co-occurrence analyses.",{"name":120,"@type":111,"acceptedAnswer":121},"Which genetic alterations were most frequently observed, and how did subtypes differ?",{"text":122,"@type":114},"TP53 was most frequently mutated (53%), followed by KRAS (18%), ARID1A (9%), IDH1 (7%), and PIK3CA (7%). IDH1 mutations were primarily seen in CCA, while STK11 mutations were exclusive to GBC.",{"name":124,"@type":111,"acceptedAnswer":125},"What link did the study find between SMAD4 loss and immune features?",{"text":126,"@type":114},"PD-L1–negative tumors showed distinct alterations, including SMAD4 mutations, which were associated with reduced PD-L1 expression. The loss of SMAD4 in TGF-β signaling could affect immune response regulation and support immune evasion.","https://schema.org",{"og:url":83,"og:type":129,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":131,"canonical":83},"index,follow",{"doc_id":133,"site_id":62},352446,1790145532,{"code":4,"msg":5,"data":136},{"doc_id":133,"user_id":137,"nickname":92,"user_avatar":138,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":46,"preview_page_count":19,"preview_urls":149},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Actionable genomic landscape of biliary tract cancer in the Indian population  \nSewanti Limaye1, *,‡,, Aditya Shreenivas2,‡, Darshana Patil3, SoumilVyas4, Irene A. George5,6, Janani Sambath5,6, Shambhavi Singh1, Chetan Madre1, Anjali Parab1, Pritam Kataria1, Darshit Shah1, Niyati Shah1, Shaheenah Dawood7, Nitesh Rohatgi8, Ruturaj Deshpande1, Aakriti Datta3, Humaid Al Shamsi9, Andrew Gaya10, Ashok Kumar Vaid11, Shriniwas Kulkarni12, Senthil Rajappa13, Damian Rieke14,, Prashant Kumar3, 15, *, Rajan Datar3, Milind Javle16,  \n1Department of Medical and Precision Oncology, Sir H N Reliance Foundation Hospital and Research Centre, Mumbai 422010, India 2Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Centre, Duarte, CA 422010, United States 3Datar Cancer Genetics, Nashik, Maharashtra 422010, India  \n4Department of Surgical Oncology, Sir H N Reliance Foundation Hospital and Research Centre, Mumbai 51122, India 5Manipal Academy of Higher Education (MAHE), Manipal, Karnataka 576104, India  \n6 Institute of Bioinformatics, International Technology Park, Bangalore, Karnataka 560066, India 7Mediclinic Parkview Hospital, Dubai 51122, United Arab Emirates (UAE)  \n8Department of Medical Oncology, Fortis Memorial Research Institute, Gurugram 122002, India  \n9Founder and Director of the Medical Oncology Service at Burjeel Medical City, 9054, United Arab Emirates 10Guy’s and St Thomas’ NHS Foundation Trust, University of London, Great Maze Pond SE1 9RT, London 11Department of Medical Oncology and Hematology Medanta the Medicity, Gurugram 122001, India 12Department of Medical Oncology Sahyadri Super Speciality Hospital, Pune 411004, India  \n13 Basavatarakam Indo-American Cancer Hospital and Research Institute, Banjara Hills, Hyderabad 13353, India  \n14Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin 13353, Germany  \n15Koita Centre for Digital Health—Indian Institute of Technology Bombay, Mumbai 400076, India  \n16Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, MD Anderson Centre in Houston, TX 77030, United States *Corresponding authors. Sewanti Limaye, Department of Medical and Precision Oncology, Sir H N Reliance Foundation Hospital and Research Centre, Mumbai, India. E-mail: [limayesewanti@gmail.com](limayesewanti@gmail.com); Prashant Kumar, Koita Centre for Digital Health—Indian Institute of Technology Bombay, Mumbai, 400076, India. E-mail: [prashant.agarwal@datarpgx.com](prashant.agarwal@datarpgx.com).  \n‡These authors have contributed equally to this paper.  \nAbstract  \nBackground: Biliary tract cancers (BTCs), including gallbladder cancer (GBC) and cholangiocarcinoma (CCA), are rare but aggressive malignancies with distinct molecular landscapes and poor prognoses. Genomic profiling has revealed significant molecular alterations, but the genomic landscape of BTC in the Indian population remains underexplored. This study aims to comprehensively characterize the mutation landscape of BTC in the Indian population.  \nMethods: A total of 154 BTC cases, including 69 CCA and 85 GBC, were retrospectively analyzed using data collected from various targeted sequencing panels. Somatic mutations, copy number variations (CNVs), and gene fusions in key oncogenic and tumor suppressor genes were identified from these panel reports. Downstream analyses were performed to derive key biological insights, including pathway enrichment and mutual exclusivity and co-occurrence analyses of genomic alterations.  \nResults: TP53 was the most frequently mutated gene (53%), followed by KRAS (18%), ARID1A (9%), IDH1 (7%), and PIK3CA (7%) . Recurrent amplifications were observed in MYC (12%) and ERBB2 (9%) . Pathway enrichment analysis revealed significant dysregulation in the PI3K-AKTmTOR, Notch, and Wnt/β-catenin signaling pathways. Notably, I","cbCaidXSfGqFmFxb","https://ap.wps.com/l/cbCaidXSfGqFmFxb","pdf",2395242,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Implications for Practice","[{\"question\":\"What was the study’s main goal regarding biliary tract cancer in India?\",\"answer\":\"To comprehensively characterize the mutation and genomic alteration landscape of BTC in the Indian population, including subtype-specific differences and immune-related associations.\"},{\"question\":\"How were genomic alterations identified in the 154 BTC cases?\",\"answer\":\"Researchers retrospectively analyzed 154 BTC cases using data from targeted sequencing panels, detecting somatic mutations, copy number variations, and gene fusions, then running pathway enrichment and mutual exclusivity/co-occurrence analyses.\"},{\"question\":\"Which genetic alterations were most frequently observed, and how did subtypes differ?\",\"answer\":\"TP53 was most frequently mutated (53%), followed by KRAS (18%), ARID1A (9%), IDH1 (7%), and PIK3CA (7%). IDH1 mutations were primarily seen in CCA, while STK11 mutations were exclusive to GBC.\"},{\"question\":\"What link did the study find between SMAD4 loss and immune features?\",\"answer\":\"PD-L1–negative tumors showed distinct alterations, including SMAD4 mutations, which were associated with reduced PD-L1 expression. The loss of SMAD4 in TGF-β signaling could affect immune response regulation and support immune evasion.\"}]","Actionable genomic landscape of biliary tract cancer in the Indian population | PDF",1790099670,[150,154,158,162],{"page_no":8,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/be264ffdb197bbc8e78df13c66b5ff35.webp",983,1291,{"page_no":14,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/47317e84737a6d7fd2fe90c5a30d5463.webp",982,1290,{"page_no":81,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/798438a26928e59c1e931183720eb689.webp",981,1289,{"page_no":19,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/16a433f09716a5a493e988bd1b3627eb.webp",980,1287]